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Summary.-Human and rat normal tissues and tumours have been studied for the
presence of toxic substances, possibly of importance in the development of cachexia
in patients with cancer and other chronic diseases. The toxic effect oftissue extracts
was gauged bymeasuringthe inhibition of growth of mouse L-cells in 1-ml cultures,
as revealed by reduced incorporation of ['4C]leucine into cell protein.
A common cytotoxic substance ofmol. wt. approximately700 daltons was isolated
from all rat and human tissues tested, including tumours. The isolation procedure
involved tissue homogenization, followed by pressure dialysis, gel filtration of con-
centrated pressure dialysates, cation exchange chromatography, and thin layer
chromatography. Amounts isolated from different tissues varied by a factor of 3.
The purified substance reacted with ninhydrin and a few other reagents for amino
groups. Itwascompletely resistant toacid and enzymatichydrolysis. Theevidence
thus suggests that the substance is an amine. It is toxic to L-cells, HeLa cells and
normal rat fibroblasts in concentrations of 10-20 F&M, producing cell death and lysis
during incubation overnight.
CACHEXIA is frequently seen in patients
with advanced cancer (DeWys, 1970;
Bodansky, 1975). In a less pronounced
form, the condition may also be seen in
patients in whom no organ or function of
major importance is directly impaired by
the tumour or its metastases (Shapot,
1972). Although the problem of cachexia
is ofgreatimportancein the care and treat-
ment ofthe cancer patient, the underlying
metabolic disturbances have received rela-
tively little attention, and they are largely
still unexplained. However, several
theories have been put forward. It has
been suggested that the tumour may have
greater affinity than normal tissue for
glucose and amino acids, and thus act as
a metabolic trap for these important
nutrient factors (Wiseman and Ghadially,
1958; DeWys, 1970; Shapot, 1972). Some
tumours produce hormones or hormone-
like substances which can have profound
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influence on the metabolism of the host
(DeWys, 1970). It has also been sug-
gested that malignant tumours may
generate toxic products with general effect
on the host, and toxic substances have in
fact been isolated from some malignant
tumours and tumour effusions (Nakahara,
1967; Holmberg, 1968). However, these
theories fail to account for the fact that
cachexia may also develop in patients with
other grave diseases of some duration
(DeWys, 1970).
Evidence has accumulated that toxic
substances may be produced during in-
flammation (Wilhelm, 1973) and immune
response (Bloom, 1971; Reed and Lucas,
1975). Such processes are activated both
in neoplastic and non-neoplastic disease.
A study was therefore initiated of the
presence of toxic factors in malignant as
well as non-malignant tissues. Here we
wish to report on the purification of aO. P. B0RMER
substance which is toxic to cells in culture
and which is present in all rat and human
tissues tested.
MATERIALS AND METHODS
Cell cultures. Eagle's Minimum Essential
Medium with Earle's salts (GIBCO Biocult
Ltd., Glasgow, Scotland), 10% calf serum
(GIBCO Biocult), 100 ,ug streptomycin/ml
and 100 iu penicillin/ml was used through-
out. Cell cultures were incubated at 37°C
in an atmosphere of 500 CO2 in air.
Mouse L-cells ofclone 929 were maintained
as monolayer cultures in plastic culture flasks
(Falcon, Oxnard, California, U.S.A.). For
test cultures, the cells were trypsinized with a
0.25% trypsin solution, washed once in cell
culture medium and adjusted to the desired
density in medium.
Unless otherwise stated, test cultures
were inoculated with 105 L-cells in a total
volume of 1 ml. Included in the 1 ml volume
were 0 1 or 0-2 ml test solution, 100 jug
gentamycin (Garamycin, Schering Corpora-
tion, Kenilworth, New Jersey, U.S.A.) and
0-05 or 0-1 iCi L[U-14C]leucine (324 mCi/
inmol) (TheRadiochemical Centre, Amersham,
England). 1-6 x 10-cm plastic culture tubes
(Falcon) were used for all test cultures.
In one experiment, HeLa cells and normal
rat fibroblasts were used. The HeLa cells
were maintained and treated as described for
the L-cells, while normal rat fibroblasts were
obtained by trypsinization of minced skin
and subcutaneous tissue from newborn rats
and maintained in culture for 10 days before
useinexperiments. Experimental conditions
with these cell types were as described for
the L-cells.
All test cultures were incubated over-
night (15-20 h), and their morphological
appearances were evaluated microscopically
before harvesting. Bacterial contamination
was monitored by microscopy, followed by
plating of media aliquots from suspected
cultures. In no instance was bacterial
growth detected in test cell cultures.
The cultures were washed twice by adding
3 ml phosphate-buffered saline (PBS: 0-14M
sodium chloride, OO1M sodium phosphate,
pH 7.5) centrifuging at 700 g for 5 min and
drawing off the supernatant by suction.
The cells were dissolved in 0-1M KOH,
followed by precipitation in 100/,, (w/v)
trichloroacetic acid. The precipitates were
collected on 25-mm glass fibre filters and
washed 3 times with 5 ml 10% (w/v) tri-
chloroacetic acid. The filters were trans-
ferred to counting vials and dried for 1 h at
95°C. Five ml of toluene-based scintillation
liquid was added, and the radioactivity was
neasured in a liquid scintillation spectro-
meter with 70%/ efficiency. Counting time
was chosen to give less than 2% counting
error for the uninhibited cultures. The
resultant coefficient of variation for the
incorporation of [14C]leucine into protein in a
series of control cultures was less than 30.
Tissues. Walker 256 carcinosarcoma was
maintained by transplantation to the axillary
regionof6-8-week-oldWistarrats. Tumours
were allowed to grow for 14 to 16 days,
reaching a diameter of about 2 cm. Normal
rat tissues were obtained from animals of the
same litters as the tumour-bearing ones.
The rats were killed by cervical dislocation
underlight etheranaesthesia, andthetumours
and normal tissues were removed aseptically.
Small necrotic areas were removed from the
tumours: those showing more than minimal
necrosis were discarded. Human spleen
tissue was obtained from patients with
Hodgkin's disease undergoing diagnostic
laparotomy with splenectomy. Only tissues
from histologically normal spleens were used.
All tissues were stored under sterile con-
ditions at -20°C until further processing.
Preparation of tissue extracts.-40-60 g of
each tissue was minced with scissors and
homogenized for 120-180 s (30 s per 10 g of
tissue) in 2 volumes of PBS at O°C with an
X-1020 homogenizer at 25,000 rev/min
(Internationale Laboratoriums-Apparate
GmbH, Dottingen, W. Germany). The
homogenates were centrifuged at 27,000 g for
30 min at 4°C. The precipitates were dis-
carded. Aliquots of the supernatants were
frozen and stored at -20°C for later testing.
All operations were done aseptically.
Pressure dialysis-The remaining super-
natants were pressure dialyzed with a 1 kg/
cm2 N2 pressure through 30-cm lengths of
1-cm dialysis tubing (Union Carbide Corpora-
tion, Chicago, Illinois, U.S.A.). The tubing
had previously been boiled and stored in a
buffer with 25 mM NaHCO3, 10 mm Na2B407
and 10 mm EDTA, pH 9, and was extensively
rinsed with distilled water before use.
Aliquots of the pressure dialysates were
frozen at -20°C for later testing. 45 ml of
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each pressure dialysate was freeze-dried.
The residues in the tubings were discarded.
Gel filtration. Each of the freeze-dried
pressure dialysates was dissolved in 2-25 ml
water (1/20 of their original volume), giving
total volumes of 2-65 to 2-85 ml. Precipi-
tates were removed by centrifugation. Gel
filtration of 2-3 ml of each concentrated pres-
sure dialysate was performed on a column of
Sephadex G-15 (Pharmacia, Uppsala, Sweden)
as described in the legend to Fig. 3, after the
addition of 1 mg Blue Dextran 2000 (Phar-
macia) and 0 5 ltCi [L 4,5-3H]leucine (Radio-
chemical Centre). The void volume was
determined by spectrophotometry at 640 nm
of the Blue Dextran 2000. The elution
volume of [3H]leucine was determined by
counting the 3H activity in 50 ,ul of each
fraction. The elution volume of low molecu-
lar weight salts from the concentrated
pressure dialysates was determined by
measuring conductivity with a CDM3 con-
ductivity meter (Radiometer, Copenhagen,
Denmark). The fractions indicated by
brackets in Fig. 3 were pooled and diluted to
20 ml with PBS. Six ml of each preparation
was frozen and stored at -20°C for later
testing.
Cation exchange chromatography.-Thie re-
maining 14 ml of the pooled fractions from
gel filtration was loaded on to columns of
carboxymethyl cellulose (CM-52, Whatman
Biochemicals Ltd., Maidstone, England) equi-
librated with PBS. Elution was performed
with NaCl gradients as described in the
legend to Fig. 5. The NaCl concentration of
the collected fractions was estimated from
the measured conductivity, using a standard
curve. Thefractions inthe range from O-40M
to 0-48M NaCl were pooled, as indicated
by brackets in Fig. 5. The pooled fractions
were freeze-dried, dissolved in a minimal
volume of water, and desalted on a column of
Sephadex G-15 in water. A sample of each
fraction obtained from the desalting column
was applied to a thin layer chromatography
(TLC) plate, dried and stained with ninhydrin
reagent as described in the section on
analytical TLC below. Fractions giving a
positive ninhydrin reaction were pooled.
Small volumes were removed for analytical
TLC. The remaining material was freeze-
dried, redissolved in 2 ml PBS, frozen and
stored at -20°C for later testing.
Titration of toxicity.-In one large experi-
ment, the frozen samples from each stage in
the purification procedure were thawed, and
dilutions made with PBS in small increments.
From each dilution, 0-2 ml was transferred to
test cell cultures.
Human spleen.-As seen from Fig. 5,
cation exchange chromatography of this
preparation yielded two cytotoxic compo-
nents eluted at 0-45M and 0-55M NaCl. To
evaluate the relationship between these,
100 g ofhuman spleen tissue was processed as
described above, except that no samples were
removed for later testing. The two toxic
preparations from the CM-52 column were
concentrated by freeze-drying and desalted
on a Sephadex G-15 column. From each
preparation, one part ofthe desalted material
was used in TLC experiments, while the other
one was freeze-dried and redissolved in PBS
for cell experiments.
Analytical TLC. Aliquots ofthe desalted
material, in amounts approximately inversely
proportional to their toxicity, were applied
to a cellulose TLC plate (TLC Ready Plate
G-1440, Carl Schleicher & Schiill, Dassel, W.
Germany). The plate was developed with a
mixture of80 parts 96% ethanol and 20 parts
25% (w/v) ammonia. After drying, the plate
was sprayed with a solution of 0-30% (w/v)
ninhydrin and 3%o (v/v) acetic acid in
butanol-(1), and heated for 5 min at 110°C.
Preparative TLC.-Material from human
spleen, eluted from the CM-52 column at
0.45MNaCl, wasapplied as aline on a cellulose
TLC plate. The amount applied was 10
times the minimum inhibitory dose for the
test cell cultures. The TLC plate was
developed as described in the preceding
section. One edge of the plate was stained
wvith ninhydrin, while the cellulose was
removed in 10 fractions from the rest of the
plate. Each fraction was eluted with 2 x
2 ml 500 (w/v) ammonia The eluates were
freeze-dried, dissolved in 0-2 ml PBS, and
transferred to test cell cultures.
Effect on various cells and cell concen-
trations-.Material from human spleen, eluted
from the CM-52 column at 0-45M NaCl, was
diluted with PBS in increments. From each
dilution, 0-2 ml was transferred to duplicate
cell cultuires as described in the legend to
Fig. 8.
RESULTS
In the present study, toxic factors
were looked for by testing the ability of
tissue extracts to inhibit the growth of cells
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in culture. Rather than expose the cells
to the agent to be tested for a period,
remove the agent and then measure cell
growth, it was decided to measure cell
growth in the presence of the tissue
extracts. This direct method is simpler
and seems to be more relevant to the
metabolicsituation ofthecachecticpatient.
The incorporation of [14C]leucine into cell
protein was used as a general measure of
cell growth; the results are therefore given
as counts/min incorporated per culture,
and conclusions are based on comparison
with the control cultures. To facilitate
the experiments, test material was added
to the culture tubes shortly after the
addition ofthe cell suspension, not waiting
for the cells to attach as a monolayer. In
control experiments, this rapid technique
yielded the same results as adding the test
material to established monolayer cul-
tures.
During the purification procedure,
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FIP. 1. Dose-response curves for the effect
of supernatants of homogenates frorm
different tissues on [I4C]leucine incorpora-
tion into protein ofL-cells in culture. Each
culture initially contained 105 cells in a total
volume of I ml, including the test solution
and 01 uCi ['4C]leucine. The amount of
radioactivity incorporated was measture(l
after 18 h incubation at 37°C. Further
dletails are given in the text.@*0
normal rat abdominal wall;
human spleen; 0 O normal rat liver-;
x x Walker 256 tumour.
great care was taken to avoid bacterial
contamination. However, with the large
number of manipulations involved, the
use of antibiotics in fairly high conceni-
trations in the test cell cultures was
deemed necessary. In control experi-
ments, the antibiotics inthe concentrations
used had no detectable effect on cell
protein synthesis or on the inhibitory
properties of the toxic principle.
The results in Fig. 1 show that the
supernatants from different tissues in-
hibited the incorporation of [14C]leucine
inthetestcellsto a varyingextent and with
widely differing dose-response curves. On
dialysis against large volumes of PBS, the
inhibitory effect was lost (data not
shown). The pressure dialysates from
three different tissues also showed marked
inhibitory effects, indicating a low molecu-
lar weight of the inhibitory principle(s).
As all macromolecules were removed
during pressure dialysis it was irrelevant
to correlate toxicity to any of the com-
monly used parameters, e.g. amount of
protein, during the further purification of
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F1CT. 2. Dose-response curves for the effect of
pressure clialysates from stupernatants onI
14C]Ieucine incorporation into protein of
L-cells in culture. Cell culttures wrere as
(lescribedl in legen(l to Fig. 1. * 0
normal rat abdominal wvall; C L
human spleen; O O normal rat liver;
x x Walker 256 tumour.
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the toxic principle(s). Instead, all pro-
cedures, volumes and dilutions were
strictly standardized, thereby permitting
comparison ofthe different tissue prepara-
tions, and the amount of material added
to test-cell cultures is consequently ex-
pressed in terms of volumes. Fig. 2
shows that the dose-response curves of
the pressure dialysates from rat liver,
Walker 256 tumour and human spleen
were fairly similar, while the abdominal
wall pressure dialysate had approximately
halfthe inhibitory effect ofthe other ones.
The more uniform toxicity of the pressure
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FIG. 3. Gelfiltrationofthecytotoxic factor(s)
from concentrated pressure dialysates. A
2-6 x 35-cm column of Sephadex G-15 was
eluted with PBS at 1-2 ml/min, and the
eluate collected in 2-4-ml. fractions. From
each fraction, 0-1 ml was transferred to test
cell cultures, and the effect on [14C]leucine
incorporation into protein was meastured
(ordinates). Cell cultures were as described
in legend to Fig. 1. a, void volume; b, peak
of [3H]leucine, added as a marker for the
elution of endogenous leucine from tissues;
c, peak of conductivity. Fractions indi-
cated by brackets were pooled.
dialysates compared to the corresponding
supernatants suggests thathigh-molecular-
weight interfering substances, possibly
present in different amounts in the
different preparations, were removed dur-
ing pressure dialysis. After incubation
of test cell cultures overnight, microscopic
inspection showed cell lysis in the com-
pletely inhibited cultures, while the cells
in the control and uninhibited cultures
formed uniform monolayers.
During gel filtration of the concen-
trated pressure dialysates on Sephadex
G-15, the cytotoxic activity of the Walker
tumour and rat liver preparations was
eluted corresponding to a mol. wt. of
about 700 daltons (Fig. 3). The toxic
activity from human spleen appeared in
fractions corresponding to a slightly higher
molecular weight. The normal abdomi-
nal wall preparation showed no inhibitory
effect in this system. However, when
more of this preparation was added, a
moderate inhibition of the test cells was
found (Fig. 4).
In order to rule out the possibility
that the reduced cellular incorporation of
[14C]leucine into protein was due to
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FIG. 4. Dose-response curves for the effect of
pooled fractions from gel filtration (Fig. 3)
on [14C]leucine incorporation into protein
of L-cells in culture. Cell cultures were as
described in legend to Fig. 1. 40 4
normal rat abdominal wall; D C1
human spleen; 0 O normal rat liver;
x x Walker 256 tumour.
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FiG. 5.-Cation exchange chromatography of
the cytotoxic factor(s) from the pooled
fractions after gel filtration (Fig. 3). 1-6
12-cm columns ofcarboxymethylcAlltlose
equiilibrated with PBS were loade(d with the
poole(d fractions, and elution was performed
w7ith linear gradients of NaCl in 10 mMr
sodtitum phosphate, pH 7-5, at 0-6 ml/min.
Two-ml fractions wvere collected (abscissae).
From each fraction, 0-1 ml was transferredl
to test cell cultures, and the effect on ['4C]
leucine incoiporation w%as measure(l (left
ordlinates). Cell cultures were as (lescribedi
in legend to Fig. I. NaCl con-
c-_ntration (right or(linates). Fractions in-
(licated by brackets were pooled and (le-
salted.
dilution by unlabelled leucine from tissues,
[3H]leucine was used as a marker for the
elution of unlabelled leucine in the gel
filtration experiments. The cytotoxic
effect was eluted well separated from
leucine (Fig. 3). In a second control
experiment, [3H]thymidine was added as
a marker. The cytotoxic effect was eluted
well separated from the thymidine (data
not shown), ruling out the possibility that
the inhibition of cell growth could be due
to the presence of thymidine in the
extracts.
In the cation exchange chromato-
graphy, the cytotoxic activity was eluted
with 0-45M NaCL in the case ofthe Walker
tumour, rat liver and human spleen
preparations (Fig. 5). The human spleen
in addition gave a second peak of toxic
activity which was eluted at 0-55M NaCi.
Again, the inhibitory effect ofthe abdom-
inal wall preparation was not detected in
the first instance. However, when larger
amounts ofthe material eluted with 0-45M
NaCl was added to the test cell cultures,
a slight inhibition was found even with this
preparation (Fig. 6). It is seen that the
other preparations gave complete inhibi-
tion of protein synthesis, and microscopic
examination after incubation overnight
showed cell lysis in the inhibited cultures.
The material eluted with 045M NaCl
was desalted and subjected to analytical
TLC. The same pattern was found for all
preparations, including the one from the
abdominal wall, with two partly con-
fluencing ninhydrin-positive spots with
RF values of approximately 0 55 and 065,
as indicated in the top section of Fig. 7.
In different experiments, the relative
40
0
P1 added per 1ml culture
FIG. 6. Dose-response curves for the effect of
pooled an(l (lesalte(l fractions from cation
exchange chromatography (Fig. 5) on [14C]
leucine incorporation into protein of L-cells
in culture. Cell cultures were as describe(d
in legeind to Fig. 1. * * normal rat
abdominal wall; E], , hutman spleen;
0 0 normal rat liver; x x Walker
256 tumour.
364365 A CYTOTOXIC FACTOR FROM TISSUES
0-
x
a
u
%-
la
0
0UL
0.5 1.0
RF
Fi(e. 7. Relationship of ninhydrin-positive
material (shaule(d ar eas in top section) to
cytotoxic effect. Preparative thin layer
chromatography of toxic material from
human spleen, elutedl firom the ion-exchange
column at 0-45Mi NaCl. One edge of the
TLC plate wvas stainedl with ninhydrin (top
section). From the rest of the plate,
material was eluted an(l teste(l for effect on
[14C]leucine incorporation in test cell
cutltures (bottom sectioin).
intensity of the two spots varied consider-
ably, depending on the desalting pro-
cedure. This suggests that the two spots
may represent different salts or complexes
of the same substance. It should be
noted that in three independent prepara-
tive TLC experiments, only one of the
spots wasfoundtorepresenttoxic material.
A typical experiment is shown in Fig. 7.
When the toxic fractions from cation
exchange chromatography of the human
spleen preparation (Fig. 5) were desalted
on a Sephadex G-15 column, the toxic
material eluted with 0-55m appeared to
have a slightly higher molecular weight
than the material eluted at 0-45M NaCl.
This may explain the fact, pointed out
above, that in the gel filtration experi-
ments (Fig. 3) the toxic activity of human
spleen pressure dialysate was eluted cor-
responding to a higher molecular weight
than the toxic activity of the other
pressure dialysates.
The second toxic material from human
spleen, when subjected to TLC, gave weak
ninhydrin-positive spots in the same
positions as the other preparations, indi-
cating a relationship to these, but with a
pronounced trailing of ninhydrin-positive
material.
Approximately 8% of the total toxic
activity present in the pressure dialysates
from Walker tumour and rat liver was
recovered after the cation exchange
chromatography. For the human spleen
pressure dialysate, about 50% of the
total toxic activity was accounted for by
the material eluted from the cation
exchange column with 0-45M NaCl.
In large-scale purification from pig
spleen, the results obtained were essen-
tially as with human spleen, except that
about 25%0 of the toxicity was recovered
in the fractions eluted from the cation
exchange column with 0-45M NaCl.
After desalting, 6-5 ,ug of this material
inhibited completely the [14C]leucine
incorporation in the -ml test cell cultures.
Taking the molecular weight to be 700
daltons, this corresponds to a concentra-
tion of approximately 10 //M.
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Fih. 8. Effect of toxic material from human
spleen on various cell types. Increasing
amounts of material, elute(l from the ion
exchange column at 0-45m NaCl, were
ad(ledI to cell cultures, an(d the effect on
[14C]leuCine incorporation wx'as measured.
Cell cultures were inoctulated with 105 L-
cells ( O O-F), :3 x 15L-cells(*
105 HeLa cells ( A Ab) or 105 normal rat
fibroblasts (A A) in 1-ml final volutmes.
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The material is toxic to all cell types
tested, as shown in Fig. 8. However, the
HeLa cells are approximately half as
sensitive as the other ones.
In attempts to characterize the toxic
principle chemically, numerous tests were
made for various functional groups. The
spots on the TLC plates could be developed
by ninhydrin, as indicated above. Fur-
thermore, they could be developed by an
o-tolidine/KI reagent after chlorination,
indicating the formation of a chloramine
(Krebs, Heusser and Wimmer, 1967).
Weak spots in the same position were also
developed by a sodium nitroprusside/
acetaldehyde reagent for secondary amines
(Krebs et al., 1967). Tests for carbo-
hydrates, lipids and aromatic or hetero-
cyclic compounds were negative.
Treatment with 6M HCI at 120°C for
96 h gave no hydrolysis, as judged by
TLC. Treatment with trypsin, pepsin,
papaine, o-chymotrypsin, pronase or
RNAse likewise failed to affect the
cytotoxicity.
DISCUSSION
In the present work, a cytotoxic sub-
stance with mol. wt. approximately 700
daltons has been detected in all human
and rat tissues tested. The substance is
toxic to all cell types tested in vitro in a
concentration ofapproximately 10-20 /IM,
producing cell lysis during incubation
overnight. Irrespective of the tissue of
origin, its behaviour in ion exchange and
TLC experiments is the same, indicating
one well-defined substance. In the case
ofhumanspleen, there appears to exist also
a related second toxic substance ofslightly
higher molecular weight.
TLC of the purified preparations con-
sistently gave two spots, one of which has
been shown to represent toxic material.
The other one may represent a derivative
of this material. Other contaminating
material has not been detected on the
TLC plates during the attempts at identi-
fication, and it is therefore probable that
the toxic substance is reasonably pure.
The tests for various functional groups
were largely negative. The few positive
results all indicate the presence of amino
groups. The extreme resistance of the
substance to acid hydrolysis seems to rule
out a peptide, leaving an amine as the most
probable candidate. However, the possi-
bility cannot be entirely ruled out that
this amine-like substance is a nontoxic
contaminanit. WAork is now in progress
to identify the toxic substance.
The recovery of cytotoxic activity
during purification was low in the small-
scale experiment described here. Large-
scale preparations have given considerably
better yields, and the low recovery may
therefore be due to losses by adsorption
during the purification procedure. Fur-
thermore, the similarity of the dose-
response curves of the puirified products
(Fig. 6) and those of the pressure dia-
lysates (Fig. 2) indicates that the substance
purified is responsible for the toxic
activity of the pressure dialysates.
The relationship of the purified sub-
stance to the many toxic factors described
in the literature is obscure. A few toxic
substances have reportedly been isolated
from tumour tissue only. Of these, the
toxohormone was originally described by
Nakahara as a protein, but later it has
been suggested that it might be a complex
of a protein and a toxic substance of low
mol. wt. (Nakahara, 1967). However,
this question does not seem to have been
studied further. The cell-growth-inhibit-
ing substance isolated by Holmberg from
tumours and tumour effusions was a well-
defined peptide (Holmberg, 1968), and
thus has no relation to the present
substance.
During recent years, several toxic or
growth-inhibiting factors from normal
tissues or cells in culture have been
described. Most of these have originated
from research in immunology or growth
regulation. Comprehensive reviews of
such factors have appeared recently
(Bloom, 1971; Lozzio et al., 1975; Reed and
Lucas, 1975). A few of the factors
described may be related to the present
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substance; however, none ofthem has been
reported to be purified to a degree per-
mitting comparison with the substance
isolated here.
The amounts of the present toxic
substance isolated from different tissues,
including tumours, vary by a factor of 3
when related to tissue wet weight. This
may indicate that the toxic substance is
present in all cells. Possibly it is released
during cell death, which can be prominent
in tumours (Steel, 1967) and in other
diseases. As the substance is toxic to all
cell types tested, an influence on the
function of cells, e.g. lymphocytes, locally
in tumours or other diseased tissue can be
anticipated. Another possibility is that
the toxic principle is present in specialized
cells, such as macrophages, and that it is
released from these in immune reactions
or during inflammation. These possibili-
ties arenowbeinginvestigated. Attempts
to demonstrate the toxic principle in the
circulation oftumour-bearing animals and
cancer patients have so far been unsuc-
cessful. The negative results are perhaps
not surprising. Due to its low mol. wt.,
the toxin is probably excreted rapidly
through the kidneys. Moreover, in vitro
experiments indicate that the toxic sub-
stance is absorbed by the target cells. It
is therefore probable that the toxin is
rapidly removed from the circulation and
that hence its concentration in the blood
at any time will be very low. The
demonstration in the serum may therefore
require more sensitive methods than those
hitherto used. Further work is in pro-
gress to elucidate whether the toxic sub-
stance can be absorbed from tumours or
other diseased tissues and exert general
effects on the metabolism of patients, i.e.
play a role in development of cachexia.
I am indebted to Ms. Bente Johansen
for skilled technical assistance, and to
Professor Alexander Pihl for valuable help
in preparing the manuscript.
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